ArticleClinical and translational medicine2021
Integrated biomarker profiling of the metabolome associated with impaired fasting glucose and type 2 diabetes mellitus in large-scale Chinese patients.
Open access · goldAbstract readLetter
In one paragraph
Article in Clinical and translational medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 41 citations in OpenAlex.
- Mining biomarkers for type 2 diabetic nephropathy based on urinary proteomics and metabolomics.Frontiers in endocrinology · 2026Article
- Lactobacillus murinus alleviates insulin resistance via promoting L-citrulline synthesis.Journal of endocrinological investigation · 2025Article
- Cancer Drug Sensitivity Prediction Based on Deep Transfer Learning.International journal of molecular sciences · 2025Article
- Serum Lipidomic Analysis of T2DM Patients: A Potential Biomarker Study.Diabetes, metabolic syndrome and obesity : targets and therapy · 2025Article
- Impact of Phenylketonuria on the Serum Metabolome and Plasma Lipidome: A Study in Early-Treated Patients.Metabolites · 2024Article
- Integrated biomarker profiling of the metabolome associated with type 2 diabetes mellitus among Tibetan in China.Diabetology & metabolic syndrome · 2023Article
- Profiling of Homocysteine Metabolic Pathway Related Metabolites in Plasma of Diabetic Mellitus Based on LC-QTOF-MS.Molecules (Basel, Switzerland) · 2023Article
- Empirical comparison and recent advances of computational prediction of hormone binding proteins using machine learning methods.Computational and structural biotechnology journal · 2023Review
- Integration of metabolomics and peptidomics reveals distinct molecular landscape of human diabetic kidney disease.Theranostics · 2023Article
- Review
- Impact of a long-term high-fructose diet on systemic metabolic profiles of mice.FASEB bioAdvances · 2022Article
- Significance of serum miR-29a in the occurrence and progression of diabetic nephropathy: A cross-sectional study.Journal of clinical laboratory analysis · 2022Article
- Identification of Nine mRNA Signatures for Sepsis Using Random Forest.Computational and mathematical methods in medicine · 2022Article
- Whole-Exome Sequencing Identified Genes Responsible for Thoracic Aortic Aneurysms and Dissections in three Chinese Families.Frontiers in genetics · 2022Article
- IBPred: A sequence-based predictor for identifying ion binding protein in phage.Computational and structural biotechnology journal · 2022Article
- Lysophosphatidylcholine (17:0) Improves HFD-Induced Hyperglycemia & Insulin Resistance: A Mechanistic Mice Model Study.Diabetes, metabolic syndrome and obesity : targets and therapy · 2022Article
- Identification ofComputational and mathematical methods in medicine · 2022Article
- Application of artificial intelligence and machine learning for COVID-19 drug discovery and vaccine design.Briefings in bioinformatics · 2021Article
- Alterations of the Gut Microbiota in Patients With Severe Chronic Heart Failure.Frontiers in microbiology · 2021Article
- AOPM: Application of Antioxidant Protein Classification Model in Predicting the Composition of Antioxidant Drugs.Frontiers in pharmacology · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors at 8 institutions in 1 country.
Jianglan LongBeijing Friendship Hospital, Capital Medical University, Beijing, China.
Hui YangCollege of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, Sichuan, China.
Zhirui YangBeijing Friendship Hospital, Capital Medical University, Beijing, China.
Qingquan JiaZhengzhou University First Affiliated Hospital, Zhengzhou, Henan, China.
Liwei LiuZhengzhou University First Affiliated Hospital, Zhengzhou, Henan, China.
Lingwei KongBeijing Jiaotong University Community Health Center, Beijing, China.
Huijing CuiBeijing Jiaotong University Community Health Center, Beijing, China.
Suying DingZhengzhou University First Affiliated Hospital, Zhengzhou, Henan, China.
Qian QinZhengzhou University First Affiliated Hospital, Zhengzhou, Henan, China.
Nana ZhangDepartment of Pharmacy, Kaifeng Hospital of Traditional Chinese Medicine, Kaifeng, Henan, China.
Xingzhong FengDepartment of Endocrinology and Immunology, Yuquan Hospital of Tsinghua University, Beijing, China.
Shuxun YanDepartment of Endocrinology, The First Affiliated Hospital of Henan University of CM, Zhengzhou, Henan, China.
Jinfa TangDepartment of Endocrinology, The First Affiliated Hospital of Henan University of CM, Zhengzhou, Henan, China.
Shuo ChenBeijing Physical Examination Center, Beijing, China.
Yumei HanBeijing Physical Examination Center, Beijing, China.
Tao JiangBeijing Shijitan Hospital, Capital Medical University, Beijing, China.
Zhen WenBeijing Shijitan Hospital, Capital Medical University, Beijing, China.
Ningning QiBeijing Shijitan Hospital, Capital Medical University, Beijing, China.
Kejun DengCollege of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, Sichuan, China.
Zhi SunZhengzhou University First Affiliated Hospital, Zhengzhou, Henan, China.
Hao LinCollege of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, Sichuan, China.
Dan YanBeijing Friendship Hospital, Capital Medical University, Beijing, China.ORCID 0000-0003-2985-3798
Capital Medical University · CNFirst Affiliated Hospital of Zhengzhou University · CNUniversity of Electronic Science and Technology of China · CNBeijing Jiaotong University · CNFirst Affiliated Hospital of Henan University of Traditional Chinese Medicine · CNState Intellectual Property Office · CNBeijing Hua Xin Hospital · CNKaifeng University · CN
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
BiomarkersBlood GlucoseChinaDiabetes Mellitus, Type 2FastingFemaleGlucose IntoleranceHumansMaleMetabolomeMiddle AgedBiomarkersBlood Glucose
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.